MC3 USING SIMULATIONS TO EXPLORE THE INFLUENCE OF COMPETING RISK ON TREATMENT-EFFECT
University of Michigan, Ann Arbor, MI, USA OBJECTIVES: In previous work, we explored through computer-aided simulated clinical trials how heterogeneity of baseline risk can lead to heterogeneity of treatment-effect under a variety of assumptions. We now explore how heterogeneity of competing risks affect treatment-effect heterogeneity under a variety of assumptions. METHODS: Using simulated clinical trials in which the intervention has a constant effect on diseasespecific risk (odds ratio = 0.7) but no effect on competing risk and in which outcomes in individuals are determined by varying 2 parameters: (1) the overall risk of the outcome of interest and (2) the ratio between the competing risk and the disease-specific (i.e. treatment-responsive) risk. RESULTS: Under conditions in the simulations, the odds ratio of the treatment-effect on the overall outcome is highly dependent on the ratio of the competing and disease-specific risk, decreasing as this ratio increases. Although the absolute treatment-effect increases with increasing overall risk, the odds ratio for the treatment decreases as the overall risk increases (holding constant the ratio between diseasespecific and competing risk). When disease-specific outcomes are measured, a similar relationship between treatment-effect and overall risk is observed, although the decrease in the odds ratio with increasing risk is greatly attenuated. Detecting significant treatment-effect heterogeneity (on the odds ratio scale) based on competing risk is likely to occur only when competing risk is very high or when patients can be sub-grouped by variables which distinguish between disease-specific and competing risk.
CONCLUSION:
The ratio of competing risk to disease-specific risk in a population can have an important impact on the measured treatment effect, even when disease-specific outcomes are measured. Detection of competing-risk-based treatment-effect heterogeneity may depend on the identification of risk factors that differentiate disease-specific from competing risk. Simulations can be useful to anticipate the magnitude of these effects when planning a clinical trial.
MC4 BREAKING THE SILENCE: THE EFFECTS OF EXPLICIT INSTRUCTIONS ON INCORPORATING INCOME IN TTO EXCERCISES
The institute for Medical Technology Assessment, Rotterdam, The Netherlands, 2 Institute for Clinical Epidemiology, Basel, Switzerland OBJECTIVES: The recommendation of the US Panel to incorporate productivity costs in terms of health effects (QALYs) in a cost-effectiveness analysis aroused quite some debate. A crucial yet under-explored question in this debate is whether people include effects of ill-health on income in health state valuations (HSV). The same holds for the actual inclusion in HSV of the effects of ill-health on leisure. This study aims to test whether respondents to health-state valuations using TTO questions include the effects of ill-health on income and leisure when the measure is silent on both. Moreover, it tests the consequences of explicit instructions to either include or exclude the incomeeffects in HSV. METHODS: Three questionnaires were developed and administered among the general public. Respondents were asked to value three distinct EQ-5D health-states using TTO. In version 1 respondents did not receive instructions on including or excluding income-effects in their valuations, but inclusion was assessed afterwards. In versions 2 and 3 respondents were instructed upfront to incorporate income-effects or to assume that income would not change. They were furthermore asked whether they included the effects of ill-health on leisure-time in their HSV. RESULTS: In version 1 64% of the respondents spontaneously included income-effects in their HSV. In version 2 and 3 88% included leisure-time. There were no differences in the valuations of respondents including or excluding income-effects, also in case of explicit instruction. Inclusion of leisure-time resulted in a significantly lower TTO-value in only one of the three health-states. CONCLUSIONS: Respondents do not consistently include income-and leisure-effects in their valuations. Including income-effects (spontaneously or instructed) does not seem to affect TTO-valuations and may therefore best be placed on the cost-side of the cost-effectiveness ratio. Leisure-
